Triton 1.5 Robotic System for Diagnostic Colonoscopy
- Sponsor
- Neptune Medical
- Study ID
- NCT07606963
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Colonoscopy
- Colorectal Cancer Screening
- Colorectal Neoplasms
- Gastrointestinal Endoscopy
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Diagnostic Test: Diagnostic Colonoscopy — DEVICEThis study will serve to evaluate the safety and efficacy of the Triton 1.5 System for performing diagnostic, screening, surveillance, and basic therapeutic tasks (e.g., polypectomy for lesions ≤2cm).
Study Details
This study is a prospective, single-arm, non-randomized, single-site study, focused on evaluating the safety and efficacy of the Triton 1.5 System in diagnostic and basic therapeutic colonoscopy.
Key Dates
- First listed
- May 26, 2026
- Start date
- Aug 1, 2026
- Status verified
- May 2026
- Primary completion
- Sep 30, 2026
- Completion
- Oct 15, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DIAGNOSTIC
Arms
- Other: Single ArmThis study is a prospective, single-arm, non-randomized, single-site study, which is deigned to evaluate the safety and efficacy of the Triton 1.5 System for performing diagnostic, screening, surveillance, and basic therapeutic tasks (e.g., polypectomy for lesions ≤2cm) during endoscopic procedures.
Primary Outcome Measure
Primary Safety Endpoint - Incident of Major Adverse Events within 48 Hours [ Time Frame: 48 Hours ]
Central Contacts
- Hayley Holm(650) 922-5512
- Min-Sun Son(650) 714-1803
Find similar trials
Related Studies
- Obtaining Solid Tumor Tissue From People Having Biopsy or Surgery for Certain Types of CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Performance of SGM-101 for the Delineation of Primary and Recurrent Tumor and Metastases in Patients Undergoing Surgery for Colorectal CancerPHASE3 · Recruiting · Surgimab · Duarte, California
- Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort StudyRecruiting · White River Junction Veterans Affairs Medical Center · White River Junction, Vermont
- Metarrestin (ML-246) in Subjects With Metastatic Solid TumorsPHASE1 · Recruiting · National Cancer Institute (NCI) · Fairway, Kansas